Target intelligence / Profile preview

Calcium release-activated calcium channel (CRAC channel) (CRAC channel)

Target
CRAC channel
Molecular classification
Ion channel
01

Overview

Store-operated calcium entry (SOCE) channels, specifically the calcium release-activated calcium (CRAC) channels, are the primary route for calcium influx in mast cells and basophils following antigen stimulation (Parekh & Putney, 2005, Physiol Rev). These channels are formed by the interaction of the endoplasmic reticulum (ER) calcium sensor STIM1 and the plasma membrane pore-forming protein Orai1 (Vig & Kinet, 2009, Nat Immunol). When IgE-mediated signaling triggers the depletion of ER calcium stores, STIM1 undergoes a conformational change and translocates to the plasma membrane to activate Orai1, leading to a sustained increase in cytosolic calcium (Hogan et al., 2010, Nat Immunol). This calcium signal is indispensable for the degranulation process, which releases histamine and proteases, as well as the de novo synthesis of leukotrienes and pro-inflammatory cytokines (Di Capite et al., 2011, Curr Opin Allergy Clin Immunol). Consequently, CRAC channels are considered high-priority therapeutic targets for allergic and inflammatory diseases such as asthma and chronic urticaria (Zhang et al., 2020, Front Immunol). Pharmacological inhibition of these channels aims to suppress the hyper-responsiveness of mast cells and basophils, thereby reducing the severity of allergic reactions.

Other names
Store-operated calcium channelSOCE channelOrai1/STIM1 complexCalcium release-activated calcium channel protein 1Orai1STIM1
02

Mechanism of action

Inhibition of the Orai1 pore-forming subunit or disruption of the STIM1-Orai1 interaction to prevent store-operated calcium entry (SOCE).

03

Biological functions

Immune responseSignal transductionDegranulationCytokine productionLeukotriene synthesis
04

Disease associations

AsthmaAllergyAnaphylaxisAtopic dermatitisChronic urticariaInflammation
05

Safety considerations

Potential for systemic immunosuppression (Feske, 2007, Nat Rev Immunol)Inhibition of T-cell activationOff-target effects on other Orai isoformsPotential impact on muscle function or sweat gland activity (Stiber et al., 2008, Nat Cell Biol)
06

Interacting drugs

CM4620 (Auxora)

4 more in the full profile.

07

Biomarkers

Intracellular calcium concentrationCD63 expressionCD203c expressionHistamine releaseIL-4 levelsIL-13 levels

Beyond the preview

Go deeper on Calcium release-activated calcium channel (CRAC channel) (CRAC channel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium release-activated calcium channel (CRAC channel) (CRAC channel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call